Riddell, L A <br/><br/>
A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease.  [electronic resource] 

 -  AIDS research and human retroviruses  Jun 2001 
 - 789-97 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0889-2229 
<br/><br/><label>Standard No.: </label>10.1089/088922201750251981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--prevention & control<br/>Anti-Infective Agents--adverse effects<br/>Consumer Product Safety<br/>Double-Blind Method<br/>HIV-1<br/>Humans<br/>Interferon-gamma--adverse effects<br/>Recombinant Proteins